Clinuvel Pharmaceuticals Stock

Invest in stocks with eToro from 50 EUR

Detail	Data
Volume (24h):	106,860 shares
P/E Ratio:	12.26
Forward P/E:	12.26
EPS:	0.77 AUD
Forward EPS:	0.77 AUD
Number of Shares:	50,123,600 shares
Market Capitalization:	473,166,752.00 AUD

The interactive chart displays the price movement of Clinuvel Pharmaceuticals shares and updates every 15 minutes. It shows both the current price and historical trends. The chart offers various time frames, including daily, weekly, or monthly views, as well as the entire trading history.

Disclaimer: The data provided is for informational purposes only. Despite our efforts to ensure accuracy, it may contain errors or be outdated. We strongly recommend verifying the data from other independent sources. No investment decisions should be made based on this information.

Dividend

The company Clinuvel Pharmaceuticals pays a dividend of 0.05 AUD per share. The annual dividend yield is 0.51%. The average dividend yield over the last 5 years is 0.22%. The payout ratio is 6.53%. The last paid dividend was 0.05 AUD, paid on 2024-09-05. The ex-dividend date, the date when shares trade without entitlement to the next dividend, is 2024-09-05.

Dividend	Value
Dividend Amount	The company Clinuvel Pharmaceuticals pays a dividend of 0.05 AUD per share.
Annual Yield %:	0.51 %
Ex-dividend Date:	2024-09-05
5-Year Avg Yield %:	0.22 %
Payout Ratio:	6.53 %
Last Dividend Value:	0.05 AUD
Last Dividend Date:	2024-09-05

Analyst Forecast

Most analysts have issued a none recommendation for Clinuvel Pharmaceuticals stock. The current number of analysts covering this company is 6. The highest target price is 39.45 AUD, while the lowest target price is 15 AUD. The median target valuation set by analysts is 22.655 AUD. These forecasts and recommendations provide insight into how analysts view the future stock performance of Clinuvel Pharmaceuticals.

Analysts	Recommendation
Issued Recommendation:	According to our data, the recommendation for Clinuvel Pharmaceuticals stock is: none
Number of Analysts:	6
Highest Target Price:	39.45 AUD
Lowest Target Price:	15 AUD
Median Target Price:	22.655 AUD

Fundamental Indicators

Indicator	Data
Total Revenue:	91,024,600.00 AUD
Net Income:	38,775,652.00 AUD
Price-to-Book (P/B):	2.18
PEG Ratio:	/
Exchange:	ASX
Industry:	Biotechnology
Sector:	Healthcare
Number of Employees:
Country:	Australia

Where to Buy Clinuvel Pharmaceuticals Stock?

You can purchase Clinuvel Pharmaceuticals stock on the ASX under the ticker symbol: CUV.AX. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

*To verify the availability of specific stocks on the platform, it's a good idea to first open a free demo account. Not all stocks are available.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5

Invest in Stocks with eToro

★★★★★ 5.0

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5

Try Free Demo Account

★★★★☆ 4.8

Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Clinuvel Pharmaceuticals Stock

Indicator	Value
Company Revenue:	91,024,600.00 AUD
EBITDA:	51,728,416.00 AUD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share:	0.77 AUD
Book Value Per Share:	4.34 AUD
Total Cash:	198,220,752.00 AUD
Total Cash per Share:	3.96 AUD
Total Debt:	715,377.00 AUD
Debt to Equity Ratio:	0.00
Quick Ratio	16.37
Current Ratio	17.37
Free Cash Flow	12,731,025.00 AUD
Operating Cash Flow	23,826,384.00 AUD
Gross Margins	90.83 %
EBITDA Margins	56.83 %
Operating Margins	45.65 %
Profit Margins	42.60 %
Return on Assets	14.2 %
Return on Equity	19.6 %
Earnings Growth (1 year)	32.1%
Revenue Growth (1 year)	8.7 %
Quarterly Earnings Year-over-Year Growth	28.7 %
Market Capitalization	473,166,752.00 AUD
Enterprise Value	289,652,320.00 AUD
EV/Revenue	3.182
EV/EBITDA	5.599
Float Shares	41,366,848 shares
Shares Outstanding	50,123,600 shares
Held Percent Insiders	0.17 %
Held Percent Institutions	8.52 %
Shares Short	-
Shares Short Prior Month	-
Date Short Interest	-
Short Percentage of Total Shares	-
Short Ratio	-
Beta	0.77
Short Percentage of Float	-
Implied Shares Outstanding	50,123,600

Frequently Asked Questions (FAQ)

1️⃣ Does Clinuvel Pharmaceuticals pay dividends?

The company Clinuvel Pharmaceuticals pays a dividend of 0.05 AUD per share. At this rate, the annual yield is 0.51 %.

2️⃣ Where to buy Clinuvel Pharmaceuticals shares?

Clinuvel Pharmaceuticals shares are traded on the ASX stock exchange under the ticker: CUV.AX. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

3️⃣ What is the forecast for Clinuvel Pharmaceuticals shares?

According to our data, the recommendation for Clinuvel Pharmaceuticals shares is from a total of 6 analysts. The average target price prediction is 22.655 AUD per share.

4️⃣ What is the total number of shares and the value of Clinuvel Pharmaceuticals on the stock exchange?

The total number of Clinuvel Pharmaceuticals shares on the exchange is 50,123,600.00 shares, which at the current market capitalization gives the company a total valuation of 473,166,752.00 AUD.